Nyra Medical
Atlanta, US · Founded 2018 · Delaware corporation · 4 known investors
Find your way into Nyra Medical
Sign up to see every warm intro you have to Nyra Medical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Nyra Medical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Nyra Medical develops the CARLEN (Cardiac Leaflet Enhancer) system, a transcatheter single-leaflet device for repairing functional mitral regurgitation while preserving native valve function. It targets both TEER-suitable patients and those with limited existing treatment options in the cardiology/medical device field.
Founders & leadership
Nyra Medical was founded in 2018 by Dr. Murali Padala, Dr. Eric Sarin, Dr. Kirthana Suresh, and Sai Muralidhar Padala.


Board
Investors · 4
How we know: the company's own site · Broadview Ventures's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Epidarex Capital's portfolio page · the company's own site · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: the company's own site · the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$12M disclosed across 1 round · 2022
▶$12MraisedNov 2022 · 14 investors · BiotechnologyRule 506(b)
- Sai Muralidhar PadalaExecutive Officer, Director
- Amrinder SinghDirector
- Eric SarinDirector
- Gowri RamanDirector
- Lisa Wipperman HeineDirector
- Offering amount
- $20M
- Amount sold
- $12M
- Proceeds to insiders
- $100K
- First sale
- Nov 2022
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 5
Companies working in the same space as Nyra Medical.
Frequently asked questions
- What does Nyra Medical do?
- Nyra Medical develops the CARLEN (Cardiac Leaflet Enhancer) system, a transcatheter single-leaflet device for repairing functional mitral regurgitation while preserving native valve function. It targets both TEER-suitable patients and those with limited existing treatment options in the cardiology/medical device field.
- Who founded Nyra Medical?
- Nyra Medical was founded by Dr. Murali Padala, Dr. Eric Sarin, Dr. Kirthana Suresh, Sai Muralidhar Padala in 2018.
- Who are Nyra Medical's investors?
- Nyra Medical's investors include Broadview Ventures, Epidarex Capital, Vensana Capital, GRA Venture.
- How much funding has Nyra Medical raised?
- Nyra Medical has disclosed $12M raised across 1 round.
- Where is Nyra Medical headquartered?
- Nyra Medical is headquartered in Atlanta, US.







